v3.26.1
STOCKHOLDERS' EQUITY (Tables)
 6 Months Ended
Jun. 30, 2026
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock-based Compensation Expense
Three Months Ended
June 30,		Six Months Ended
June 30,
(in thousands)2026202520262025
Cost of revenue
$6,752 $7,288 $14,628 $15,111 
Selling and marketing
14,555 14,378 33,009 30,159 
Research and development
7,943 7,490 17,962 15,875 
General and administrative
6,976 7,574 16,442 17,010 
$36,226 $36,730 $82,041 $78,155 
Income tax benefit
$(7,091)$(566)$(16,255)$(1,153)
Schedule of Stock-based Compensation Expense Grants
Six Months Ended
June 30, 2026
(in thousands)
Quantity
Total Fair Value
Restricted stock units (1)
2,080 $92,716 
Non-qualified stock options
3,159 $55,302 
Performance stock options (2)
1,497 $25,804 
(1) Includes units issued when employees elect to receive 50% of the employee’s target incentive compensation under the Company’s Corporate Incentive Compensation Plan (the “CICP”) in the form of RSUs instead of cash.
(2) Performance stock options allow the holder to purchase a specified number of Common Stock shares at an exercise price equal to or greater than the shares' fair market value at the grant date. Performance stock options granted in the six months ended June 30, 2026 vest on the second anniversary of the grant date, up to 200%, subject to the achievement of specified performance metrics over fiscal years 2026 and 2027. The options expire ten years from the grant date.